Bone Biologics Corp (BBLG) › Operating IncomeBone Biologics Corp (BBLG) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2013: -$672.0K2014: -$3.01M2015: -$12.00M2016: -$20.41M2017: -$2.63M2018: -$2.79M2019: -$2.45M2020: -$825.0K2021: -$1.10M2022: -$3.67M2023: -$9.43M2024: -$4.22M2025: -$3.23M-$3.23M2013Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$3.23M+23.3%2024-$4.22M+55.3%2023-$9.43M-157.2%2022-$3.67M-232.3%2021-$1.10M-33.7%2020-$825.0K+66.3%2019-$2.45M+12.3%2018-$2.79M-6.3%2017-$2.63M+87.1%2016-$20.41M-70.2%2015-$12.00M-298.5%2014-$3.01M-348.0%2013-$672.0K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share